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Abstract. The term hyperthermia is a combination of two Greek words: HYPER (rise) and THERME (heat) and refers to the increasing of body 
temperature or selected tissues in order to achieve a precise therapeutic effect. This paper reviews the development of thermotherapy by describing  
the most important moments in its history. For decades, the development of hyperthermia ran parallel with the development of cancer treatment and 
had numerous connections with electromedicine. Throughout its history, hyperthermia evoked a number of hopes, brought spectacular successes, 
but also was the subject of many disappointments. 
 
Streszczenie. Termin hipertermia stanowi połączenia dwóch wyrazów z języka greckiego: HYPER (podnosić) oraz THERME (ciepło) i odnosi się do 
podnoszenia temperatury ciała lub wybranych tkanek w celu osiągnięcia określonego efektu terapeutycznego. W niniejszej pracy dokonano 
przeglądu rozwoju terapii ciepłem przez opis najważniejszych momentów w jej historii. Przez dziesięciolecia rozwój hipertermii biegł równolegle z 
rozwojem leczenia nowotworów i miał liczne związki z elektromedycyną. W swojej historii terapia ciepłem budziła liczne nadzieje, przynosiła 
spektakularne sukcesy, ale również była przedmiotem wielu rozczarowań. (Istotne fakty z historii hipertermii i ich związki z elektromedycyną) 
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Introduction 
 Hyperthermia as a method of treating cancer has a long 
history, dating back to around 3000 B.C. The term 
hyperthermia is a combination of two Greek words: hyper 
(rise) and therme (heat) and refers to the increasing of body 
temperature or selected tissues in order to achieve a 
precise therapeutic effect. Throughout its history, hyper-
thermia evoked a number of hopes, brought spectacular 
successes, but also was the subject of many disappoint-
ments. Scientists are still looking for new techniques that 
will make hyperthermia a simpler, safer, more effective and 
widely available method for patients. The use of nano-
technology in hyperthermia treatment e.g., magnetic fluid 
hyperthermia, which is currently under experimentation, 
seems particularly promising [11]. 
 
Heat in the Ancient Times 
 The use of high temperature as a method of treatment 
of various diseases (including cancer) was common in 
various cultures since ancient times. Primarily, the heat had 
sacral meaning and was associated with the healing power 
of the Sun [16]. Therefore, it was used for the treatment of 
locally affected human body parts or the whole organism. 
For that purpose, hot water and sand (mud baths) from 
natural thermal springs, and hot air and steam occurring in 
the volcanic caves were utilized. The first known use of heat 
treatment was carried out by an Egyptian aruspice named 
Imhotep (2655 – 2600 B.C.).The Edwin Smith papyrus from 
about 1700 B.C., which is probably a copy of a thousand 
year old text, reports that the ancient Egyptians used the 
so-called "fire drills" (hot blades and sticks) for the treatment 
of breast cancer [19]. These treatments involved the 
burning of cancerous cells and had nothing to do with 
elevated body temperature. It is worth noting that the local 
and systemic hyperthermia treatments were also very 
popular in ancient China and India [1]. 
 In ancient Greece and Rome many physicians shared 
the opinion that knowledge how to control human body 
temperature will allow them to cure all diseases, including 
cancer, whose pathology was well known and described in 
those days [2]. For example, the Greek philosopher 
Parmenides (ca. 540 – ca. 470 B.C.) was deeply convinced 
of the effectiveness of hyperthermia as evidenced by the 
words: “Give me the power to produce fever and I will cure 
all diseases” [9]. This view was shared by Hippocrates 
(460 – 370 B.C.), a Greek philosopher and scientist who is 
considered the “father of medicine”. He claimed that the 
disease must be incurable, if it can not be cured by using 
heat. Moreover, Hippocrates successfully used heat to treat 
breast tumors [16]. His medical practice was based on the 
philosophy of ancient Greece, which attributed the fire to 
the highest level of intelligence and freedom [17]. Heat 
treatment was recommended after unsuccessful trials of 
surgery and when known drugs and other treatments failed. 
This conviction is well illustrated by the words of 
Hippocrates: "What medicines to not heal, the lance will; 
what the lance does not heal, fire will" [20]. Belief in the 
curative effect of fever was also shared by Celsus 
(ca. 25 B.C. – 45 A.D.), a Roman author of the first 
systematic treatise on medicine "De Medicina" and Rufus of 
Ephesus, a Greek physician who lived at the turn of the 1st 
and 2nd century [20]. Celsus described the hot baths as a 
tool in the treatment of various diseases.  
 
Hyperthermia and infectious fever 
 The first paper on hyperthermia was published in 1866 
by a German surgeon Carl D. W. Busch (1826 – 1881). He 
described the case of a 43-year-old woman with advanced 
sarcoma on her face [18]. After the tumor was removed, the 
patient fell ill with erysipelas. The disease induced high tem-
perature which led to tumor regression. Busch’s discovery 
was fundamental because it was the first reported case 
showing that high temperature can selectively kill cancerous 
cells while not affecting the healthy. This event and other 
similar reports had led to increased interest in hyperthermia 
and make many trials to induce infectious fever in patients 
with cancer, for example, by applying dirty bandages or 
blood of people suffering from malaria into open wounds 
[20]. 
 Apart from the research of Busch, the relationship 
between infection and cancer regression was looked for by 
a young American surgeon William B. Coley (1862 – 1936). 
His studies involve the injection of different types of 
bacterial pyrogens into tumors and observation of their be-
havior. In 1891 he developed a toxin that caused typical 
erysipelas with its typical fever [3]. For this reason, Coley is 
called the father of the modern use of hyperthermia and 
immunotherapy against cancer. So-called Coley'a toxin had 
been used to treat various types of cancer for nearly a 
century. Results of research conducted by Coley'a showed 
that the five year survival rate increased from 28 to 64% for 
patients with inoperable cancer depending on the 
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temperature of concurrent fever. When the temperature was 
higher the survival time was longer. However, treatment of 
an infectious fever had one basic defect – it was unpre-
dictable. Each patient responded to the toxin in a different 
way! All of this caused that over time this method was 
abandoned and physicians looked for other more effective 
cancer treatments, which gave more reproducible results. 
 
  
 
Fig.1. Carl D. W. Busch (left) and William B. Coley (right) 
 
Local and systemic hyperthermia 
 Irrepressible attempts of creating a high body 
temperature led to the development of various methods of 
systemic hyperthermia. They mainly involved wrapping the 
patient in plastic and dipping in hot wax or placing in a 
specially heated rooms or boxes. More sophisticated 
techniques required the removal of the patient's blood and 
forcing it into the body then after it had been warmed 
(perfusion hyperthermia). These all treatments were 
characterized by variable success and often led to death. 
Nevertheless, utilization of hyperthermia had been widely 
reported in the treatment of sexually transmitted diseases, 
neurological disorders, arthritis and asthma [20]. 
 Simultaneously, the local hyperthermia was used. In this 
type of treatment specific tissues or tumor were heated. For 
example, a Swedish doctor Frans J. E. Westermark (1853 – 
1941) in 1898 attempted to treat inoperable cancers of the 
uterine cervix by using high temperature water (42 – 44oC) 
circulating in a special metal coil [4]. Effectiveness of the 
treatment (ongoing for 42 hours) was confirmed by the fact 
that among the seven patients treated by Westermark, in 
one case the tumor had disappeared, and in other cases 
improvement was observed. However, due to extreme pain 
and long treatment this method was abandoned soon. 
 
Heating and early electricity 
 The first attempts of cancer treatment using electricity 
were possible after 1800, when the Italian physicist and 
physiologist Alessandro G. A. A. Volta (1745 – 1827), 
inspired by the experiences of his compatriot Luigi Galvani 
(1737 – 1798), invented the electric cell, later called voltaic 
pile. This primary form of the electric battery was a source 
of direct current. A single electric pile could generate only a 
small voltage of 1 – 2 V, but several piles connected in 
series could create a high power energy source [13]. Voltaic 
pile quickly became known worldwide and inspired many 
scientists to do further research and relevant experiment 
relevant for the development of electricity and medicine. 
 At that time there was considerable competition among 
researchers for the recognition of the priority of use of 
electricity for heating tissue. Early treatment involved 
burning the tumors by a direct passage of electrical current 
and was called galvanocautery. Electricity was applied 
directly to the diseased tissues using special needles, wires 
and knife-type electrodes (so-called "electric knife") [8]. 
Already around 1830, a French surgeon and gynecologist 
Joseph C. A. Recamier (1774 – 1852) used electric heat to 
treat of uterine cancers [16]. A much more important role in 
the use of heat in the women's oncology was played by 
American surgeon John Byrne (1825 – 1902). He was 
known for the invention of a special liquid storage battery, 
which supplied sufficient electrical current to cauterize 
pathological changes of the uterus [14]. Results of his 20-
year study were compiled in a text from 1889, in which he 
summarized the effects of treatment of the uterus and 
cervix tumors in 367 patients [16]. He confirmed the known 
evidence that "deeper lying cancer cells are destroyed by 
less heat than will destroy normal tissues". Similar 
treatments in men were carried out by the Italian surgeon 
an Enrico Bottini (1835 – 1903), who in 1874 invented a 
special device for firing prostate cancer cauterization 
named as "cauterio termogalvanico" [15]. 
 
Heating and high-frequency currents 
 After the English physicist James C. Maxwell (1831 – 
1879) formulated his theory of electromagnetism in 1873, 
and a German physicist Heinrich Hertz (1857 – 1894) 
confirmed it in 1886 by constructing an oscillator of 
electromagnetic waves (so-called the Hertz oscillator), the 
rapid development of many types of AC devices was 
imminent. One person, who drew attention to the possibility 
of using high-frequency currents for therapeutic appli-
cations, was a physicist Nikola Tesla (1856 – 1943). His 
publications in the “Electrical Engineer”, referred not only to 
the physiological effects, but also to the heating capability of 
tissues using alternating current above a certain frequency. 
Interestingly, Tesla was miraculous cured of pulmonary 
tuberculosis by the high-frequency currents in 1899 [8]. 
 However, the most famous person who established the 
ground for capacitive and inductive heating of tissues using 
high-frequency currents was a French physicist and 
physiologist Jacques-Arsene d'Arsonval (1851 – 1940). 
Already in 1981 he carried out a significant experiment in 
which he passed a current of 3A through his own body. 
What was important, he did not feel any sensation with the 
exception of heat [16]. He experienced more heating effects 
during a similar experiment in 1898, when current of 500mA 
was passed through his body. As a result of these 
experiments he introduced what he called “autoconduction” 
which was really induction under the influence of high-
frequency electromagnetic field [7]. Since that time, he 
commenced to employ high-frequency currents in the 
treatment of various diseases. 
 
  
 
Fig.2. Prof. d’Arsonval and his induction coil applicator 
 
 During the years 1894 – 1895 d'Arsonval clinically 
treated 75 patients suffering from various ailments. Each of 
them was placed in the huge induction solenoid (Fig.2) and 
was exposed to the fields for 15 – 20 minutes a day. Other 
patients were treated on a so-called condenser couch 
(Fig. 3), where currents of 350 – 450 mA were passed 
through their body for 6 minutes a day [8]. These devices 
created by d'Arsonval, enjoyed great popularity at the turn 
of the century [10] and the so-called “Arsonvalisation” have 
been widely used in the treatment of many diseases, 
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beginning from disorders of blood circulation, metabolism, 
central nervous system and skin, and ending with 
tuberculosis, gastrointestinal disorders and hemoroids. It 
was also claimed that Arsonvalisation had positive influence 
on the central thermoregulatory system of the body [16].  
 
 
 
Fig.3. D’Arsonval’s condenser couch for capacitive heating 
 
 The actual mechanisms of heating using high-frequency 
current were explained by von Zeyneck in 1899. He 
believed that the heat is generated by the passage of 
current through the tissue similarly as when the resistance 
is passed by electric current [8]. 
 In 1907  a German physician Karl Franz Nagelschmidt 
(1875 – 1952) demonstrated the possibility of deep heating 
of tissue using high frequency energy, and suggested its 
use in the treatment of blood circulation and joints diseases. 
In 1909 he introduced the concept of diathermy to 
determine the heating effects inside tissues (so-called 
"thermooperation") caused by high frequency currents [16]. 
His book on diathermy of 1913 initiated a new era of high-
frequency electrotherapy applications (Fig.4). Independently 
from Nagelschmidt, the heat tissue penetration (so-called 
“thermopenetration”) was described in 1909 by an Austrian 
physician Gottwald Schwarz (1880 – 1959), and in 1910 a 
German physician Christoph Müller performed it with 
diathermy. This treatment involved the electrical heating of 
the tissue without its destruction in order to increase blood 
flow [2]. 
 
  
 
Fig.4. Apparatus for diathermy and possible way of its application 
 
 The concept of diathermy contributed to the mistaken 
belief that the biological effects of electromagnetic fields 
were limited only to thermal effects. The development of 
powerful generators in the following years led to the 
creation of new types of diathermy techniques their 
applications in medicine. With time, apart from previously 
known longwave diathermy (0.5 – 3.0 MHz), shortwave 
diathermy with frequencies of up to 100 MHz by 1920 and 
shortwave diathermy with frequencies of 100 – 3000 MHz 
by 1930 became standard tools in medical treatments. This 
type of heating technology and high-frequency currents 
were eventually introduced into the surgery practice 
(surgical diathermy) [16]. 
 In 1927, Swedish gynecologist Nils Westermark (1892 – 
1980), the son of F. Westermark, published in his 
dissertation the results of experimental studies on the 
heating of tumors in rats with high frequency [4]. He said 
that the tumors may be more sensitive to heat than healthy 
tissues and also recommended the temperature of 40 – 
45oC for selective tumor heating. Shortwave diathermy was 
first used in 1928 by a German physician Erwin 
Schliephake (1894 – 1995) to cure a furuncle on his nose 
[8]. He initially investigated the biological effects of 
shortwave treatment on various tissue types and then 
introduced it to clinical applications. 
 
Hyperthermia and other therapies 
 The discovery of ionizing radiation in 1895 by German 
physicist Wilhelm C. Röntgen (1845 – 1923) led to the use 
of X-rays to treat cancer and temporarily reduce the interest 
in hyperthermia in the early twentieth century. Due to 
insufficient and underdeveloped heating methods and 
temperature measurement techniques, as well a the lack of 
positive clinical results, the consent to hyperthermia treat-
ment with hyperthermia had been withdrawn. Since then 
cancer was dominated by traditional surgical methods as 
well as radiotherapy and chemotherapy [18]. 
 However, already in 1910, G. Schwarz found that 
hyperthermia combined with radiotherapy gives good 
therapeutic results. In 1912, Müeller discussed in detail the 
clinical effects of radiotherapy combination with 
hyperthermia and presented the treatment results of 100 
patients with various tumors treated with long-term therapy 
[2]. In 1/3 of cases the tumors had disappeared, and 
another third part showed an improvement though with 
subsequent tumor regrowth or metastases. Ch. Müller 
recommended association treatment, but warned that "the 
deeper the tumor location, the fewer options there are for 
treatment success". Unfortunately, from the viewpoint of 
modern science that study was not a random clinical trial. 
 After 1929 E. Schliephake developed a set of paired 
electrodes to induce capacitive heating in advanced cases 
of uterine cancer. He used radio frequencies of 20 – 50 
MHz with wavelengths of 6 – 15 m for different heating 
periods of up to 40 minutes. He noticed improvement in 
tumor tissue destruction when heat treatment was 
associated with X-rays [16]. With time this method was 
modified and used for the treatment of various pelvic 
tumors. Although Schliephake’s method was successful in 
the treatment of inoperable cases, it did not find its way into 
mainstream of medicine. 
 The revival of interest in hyperthermia occurred after 
World War II, when it research on the biological reasons for 
hyperthermia began. In 1962 an American surgeon, George 
W. Crile Jr.. (1907 – 1992) made a famous discovery, 
stating that long-lasting increase of the temperature of 
some tumors to 42 – 50°C could selectively destroyed them 
without damaging the healthy tissues [18]. In 1971 
American researchers A. Westra and W. C. Dewey made 
the first serious experiment on hyperthermia of mammalian 
cells. It became an inspiration to the study radio- and 
chemo-sensitivity of tumor cells after hyperthermia 
treatments. Soon, more effective heat treatment in 
combination with radiotherapy was confirmed E. Ben-Hur. 
In 1977, Dewey proved that long-term (over 30 minutes) 
exposure of cells to temperatures exceeding 40°C resulted 
in their death [5]. Moreover, it was noted that at 
temperatures above 42.5°C, a slight increase in 
temperature (of the order of tenths of a degree) caused a 
significant increase in cell mortality. These results signalled 
the importance of accurately determining the temperature in 
hyperthermia systems, and precision of the temperature 
measurement within the tumor. At the same time 
techniques for perfusion hyperthermia with anticancer drugs 
for the treatment of tumors in isolated organs (liver, lungs) 
and limbs had been developed and standardized [12]. 
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Microwave Hyperthermia 
 A technological revolution in hyperthermia occurred 
when the microwave heating techniques were developed 
and were applied in medicine. The development of new 
technologies allowed for better options in the local heating 
of tumors, including those located deep in the human body 
(local-regional hyperthermia). During the period of 1938 – 
1939 H. E. Hollman discussed the possibility of therapeutic 
applications of 25cm waves; he predicted that the waves 
could be focused to produce the heating of the deep tissues 
without excessive heating of the skin. In 1946 the Federal 
Communications Commission assigned the frequency of 
2450 MHz to physical medicine based on its alleged 
superiority in therapeutic value [8]. Next L. L. Siems 
performed comparative studies of the effect of shortwave 
and microwave diathermy on blood flow in 1948. Two years 
later A. E. Gessler and partners probably were the first 
group of physicians to use RF energy at microwave 
frequencies in the experimental treatment of cancer. In the 
years 1977 – 1983 a Swedish oncologist Jens Overgaard, 
carried out 204 separate clinical studies with 10,265 
participating patients, which confirmed the effectiveness of 
thermotherapy in cancer treatment [4]. Since that time 
hyperthermia has been considered a standard method 
cancer therapy .In 1990 Alan J. Fenn, an electrical engineer 
at the MIT’s Lincoln Laboratory, developed a concept for 
heating deep tumors by means of adaptive microwaves. 
These adjust to the properties of a patient’s tissue to 
concentrate the microwave energy at the tumor position. 
These adaptive microwaves are generated by multiple 
microwave antennas (an adaptive phased array) that 
surround the human body [6]. 
 
Modern Hyperthermia 
 Worldwide interest in hyperthermia had become the 
starting point for organizing the International Symposium on 
Cancer Therapy by Hyperthermia and Radiation in 
Washington, D.C. (USA) in 1975. Other similar congresses 
took place in Essen (Germany) in 1977, and in Fort Collins 
(Colorado, USA) in 1980. Since then, the International 
Symposium on Hyperthermic Oncology has been held 
every four years. In 1981 the North American Hyperthermia 
Society was created and two years later the European 
Hyperthermia Institute was formed. In Japan, hyperthermia 
research started in 1978 and the Japanese Society of 
Hyperthermia Oncology was established in 1984. In 1985 
the North American Hyperthermia Society, together with the 
European Society for Hyperthermic Oncology and the 
Japanese Society of Hyperthermic Oncology cooperatively 
founded the International Journal of Hyperthermia and 
adopted it as their official journal. Currently, it is the most 
important periodical devoted to hyperthermia. In 1988, by 
combining hyperthermia with modern knowledge of bio-
electromagnetism and human physiology, a new direction in 
the fight against cancer called “oncothermia” was created, 
which is still being developed [17]. It is worth noting that in 
2010 the First International Symposium Oncothermia took 
place in Cologne (Germany) and the first issue of the 
Oncothermia Journal was published. 
 
Summary 
 Nowadays hyperthermia is an emerging effective 
treatment method in oncology. Against its long history 
hyperthermia is still in its infancy. Positive therapeutic 
effects of this treatment depend on the applied temperature, 
exposure time and the volume of the tissue exposed to 
electromagnetic fields. The effectiveness of heat treatment 
can be significantly increased by combining hyperthermia 
with other cancer treatments such as radiotherapy, chemo-
therapy, immunotherapy, and gene therapy. Hyperthermia 
has found application in the treatment of breast, skin, head 
and neck, brain, oesophagus, prostate, uterus cervix, and 
urinary bladder tumors. However, still not all mechanisms 
responsible for cell death during hyperthermia are known. 
New methods of heating are being studied all the time. 
Many opportunities presented itself with the development of 
nanotechnology and magnetic fluid hyperthermia observed 
in recent years. 
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